Telmisartan Tablet 40 mg (Telmisartan)

Adult dose

This medication is taken as an orodispersible tablet, placed on the tongue and allowed to dissolve without water. Do not crush or split the tablet. For Essential Hypertension: The adult dose is 40 mg taken orally once a day, without regard to food. If necessary, the dose can be increased up to 80 mg once a day, and the maximum blood pressure lowering effect appears 4 to 8 weeks after increasing the dose. For Reducing Risk of Cardiovascular Disease: The recommended adult dose is 80 mg taken orally once a day, without regard to food.

This medication may cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, pregnant or breastfeeding women, individuals with severe liver impairment, and patients with hereditary angioedema should not take this medication. Elderly patients, those with hyperkalemia, patients with liver disease, heart disease, or kidney disease should take this medication with caution and should regularly monitor blood pressure, kidney function, and electrolyte status. If symptoms such as excessive lowering of blood pressure, dizziness, fainting, difficulty breathing, or swelling of the face or lips occur while taking this medication, medical consultation should be sought immediately. Patients with impaired kidney function or those undergoing hemodialysis should periodically check their blood potassium and creatinine levels when taking this drug. This medication has an increased risk of side effects when taken with other antihypertensives, especially ACE inhibitors, aliskiren, and potassium-sparing diuretics, hence caution is necessary during concurrent use. Patients undergoing surgery should ideally discontinue this medication 24 hours before surgery. Caution should be exercised as dizziness or fainting may occur while driving or operating machinery. This medication contains sorbitol, so patients with fructose intolerance should avoid it. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, and immediate medical evaluation should be sought. Safety and effectiveness of this drug have not been established in children; it is advised to keep it out of reach of children and to avoid moisture and direct sunlight during storage.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory problems accompanied by cough and fever, yellowing of skin or eyes, jaundice, extreme lethargy, liver dysfunction, sudden and severe negative reactions

Mild side effects

• Upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hyperkalemia
• hypoglycemia

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius room temperature. This helps to preserve the effectiveness of the drug for a long time.

Appearance

White round orodispersible tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]